A prior study showed that inhibiting Rho-kinase suppressed apoptosis and inflammatory injury by regulating NF-κB activation in cisplatin-induced acute kidney injury [44], and our results are consistent with the previous study. This evidence concerns the gene NFKB1 and acute kidney injury.